Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pandha

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Do we know what's best for prostate cancer?J Waxman, H Pandha
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2006
Targeting renal cell carcinomaS Chowdhury, H Pandha
Lancet (London, England)|October 14, 1995
Anti-androgens in treatment of prostate cancerJ Waxman, H Pandha
British Journal of Urology|April 1, 1997
Gene therapy for prostate cancerK Sikora, H Pandha
The Lancet. Oncology|March 21, 2002
Left atrial sarcoma presenting as cerebral infarctionL Pickering, I Cox, H Pandha
Prostate Cancer and Prostatic Diseases|June 4, 2008
Prostate cancer chemotherapy in the era of targeted therapyA Michael, K Syrigos, H Pandha
Disease Markers|May 22, 2001
Detection of T cell cytokine production as a tool for monitoring immunotherapyJ John, H Pandha, A G Dalgleish
Prostate Cancer and Prostatic Diseases|September 20, 2006
Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomyN Quatan, B Meyer, M Bailey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2004
Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part IIJ Spicer, N Quatan, T Plunkett, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 3, 2004
Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part IN Quatan, J Spicer, T Plunkett, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Do we know what's best for prostate cancer?J Waxman, H Pandha
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 15, 2006
Targeting renal cell carcinomaS Chowdhury, H Pandha
Lancet (London, England)|October 14, 1995
Anti-androgens in treatment of prostate cancerJ Waxman, H Pandha
British Journal of Urology|April 1, 1997
Gene therapy for prostate cancerK Sikora, H Pandha
The Lancet. Oncology|March 21, 2002
Left atrial sarcoma presenting as cerebral infarctionL Pickering, I Cox, H Pandha
Prostate Cancer and Prostatic Diseases|June 4, 2008
Prostate cancer chemotherapy in the era of targeted therapyA Michael, K Syrigos, H Pandha
Disease Markers|May 22, 2001
Detection of T cell cytokine production as a tool for monitoring immunotherapyJ John, H Pandha, A G Dalgleish
Prostate Cancer and Prostatic Diseases|September 20, 2006
Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomyN Quatan, B Meyer, M Bailey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2004
Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part IIJ Spicer, N Quatan, T Plunkett, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 3, 2004
Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part IN Quatan, J Spicer, T Plunkett, et al.
Pageof 4